Zacks Research upgraded shares of Hyperion DeFi (NASDAQ:HYPD – Free Report) from a strong sell rating to a hold rating in a report released on Thursday morning,Zacks reports.
A number of other equities research analysts have also weighed in on HYPD. Weiss Ratings raised shares of Hyperion DeFi from a “sell (d)” rating to a “sell (d+)” rating in a report on Tuesday, September 1st. Chardan Capital raised their target price on Hyperion DeFi from $7.30 to $8.45 and gave the stock a “buy” rating in a research note on Tuesday. Finally, Cantor Fitzgerald reaffirmed an “overweight” rating and set a $11.20 price target (up from $7.10) on shares of Hyperion DeFi in a research report on Thursday. Two equities research analysts have rated the stock with a Buy rating, one has given a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, the stock presently has an average rating of “Hold” and an average price target of $9.82.
Check Out Our Latest Stock Report on Hyperion DeFi
Hyperion DeFi Stock Performance
Hyperion DeFi (NASDAQ:HYPD – Get Free Report) last released its earnings results on Thursday, August 13th. The company reported $0.92 earnings per share for the quarter. Hyperion DeFi had a net margin of 416.56% and a negative return on equity of 11.62%. The company had revenue of $0.36 million for the quarter. Sell-side analysts expect that Hyperion DeFi will post 1.78 EPS for the current year.
Institutional Trading of Hyperion DeFi
Large investors have recently made changes to their positions in the business. Redwood Wealth Management Group LLC grew its holdings in Hyperion DeFi by 2.1% during the first quarter. Redwood Wealth Management Group LLC now owns 183,273 shares of the company’s stock worth $632,000 after acquiring an additional 3,690 shares during the period. Price T Rowe Associates Inc. MD acquired a new position in Hyperion DeFi in the fourth quarter valued at approximately $73,000. State Street Corp acquired a new stake in shares of Hyperion DeFi during the 4th quarter worth approximately $92,000. Jane Street Group LLC acquired a new stake in shares of Hyperion DeFi during the 4th quarter worth approximately $493,000. Finally, Renaissance Technologies LLC purchased a new position in shares of Hyperion DeFi during the 4th quarter valued at approximately $663,000. 25.84% of the stock is owned by hedge funds and other institutional investors.
Hyperion DeFi Company Profile
Eyenovia, Inc, an ophthalmic technology company, engages in the development of therapeutics based on its proprietary microdose array print platform technology. The company's product candidates include MicroPine, which is in Phase III clinical development program with indications for pediatric myopia progression (near-sightedness); MicroLine, which is in Phase III clinical development program with indications for the improvement in near vision in people with presbyopia; and Mydcombi, which is in Phase III clinical development program with indications for pharmaceutical mydriasis.
Featured Stories
- Five stocks we like better than Hyperion DeFi
- MarketBeat Week in Review – 09/07 – 09/11
- Block Makes a Federal Trust Bank Move That Could Reshape Its Fintech Model
- Kroger’s Textbook Entry for Buy-and-Hold Investors
- AST SpaceMobile Looks to Extend Its 30-Day FCC Satellite Testing Window
Receive News & Ratings for Hyperion DeFi Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hyperion DeFi and related companies with MarketBeat.com's FREE daily email newsletter.
